Literature DB >> 11259480

Axonal transport of VR1 capsaicin receptor mRNA in primary afferents and its participation in inflammation-induced increase in capsaicin sensitivity.

C Tohda1, M Sasaki, T Konemura, T Sasamura, M Itoh, Y Kuraishi.   

Abstract

Capsaicin receptors are expressed in primary sensory neurons and excited by heat and protons. We examined the inflammation-induced changes of the level of VR1 capsaicin receptor mRNA in sensory neurons and the sensitivity of primary afferents to capsaicin. Carrageenan treatment induced axonal transport of VR1 mRNA, but not that of preprotachykinin mRNA, from the dorsal root ganglia to central and peripheral axon terminals. The sensitivity of central terminals to capsaicin, which was estimated by measuring the capsaicin-evoked release of glutamate from the dorsal horn, was increased by peripheral inflammation, and such an increase was suppressed by inhibiting the RNA translation in the dorsal horn with cycloheximide and an intrathecal injection of VR1 antisense oligonucleotides. Thus, peripheral inflammation induces the axonal transport of VR1 mRNA, which may be involved in the hypersensitivity of primary afferents to capsaicin and the production of inflammatory hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259480     DOI: 10.1046/j.1471-4159.2001.00193.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  39 in total

1.  Implantation of tumoral XC cells induces chronic, endothelin-dependent, thermal hyperalgesia in mice.

Authors:  Ana Baamonde; Ana Lastra; Manuel F Fresno; Sara Llames; Alvaro Meana; Agustín Hidalgo; Luis Menéndez
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

Review 2.  Local translation of mRNAs in neural development.

Authors:  Hosung Jung; Christine E Holt
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-10-19       Impact factor: 9.957

3.  TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury.

Authors:  Koichi Obata; Hirokazu Katsura; Toshiyuki Mizushima; Hiroki Yamanaka; Kimiko Kobayashi; Yi Dai; Tetsuo Fukuoka; Atsushi Tokunaga; Makoto Tominaga; Koichi Noguchi
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

4.  Fragile X mental retardation protein (FMRP) and the spinal sensory system.

Authors:  Theodore J Price; Ohannes K Melemedjian
Journal:  Results Probl Cell Differ       Date:  2012

5.  Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization.

Authors:  Irina Vetter; Wei Cheng; Madusha Peiris; Bruce D Wyse; Sarah J Roberts-Thomson; Jie Zheng; Gregory R Monteith; Peter J Cabot
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

Review 6.  The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Jing Yu; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015-07-15       Impact factor: 2.581

7.  Complexity of systems and actions underlying neurogenic inflammation.

Authors:  Tony L Yaksh; Anna Di Nardo
Journal:  Semin Immunopathol       Date:  2018-05       Impact factor: 9.623

Review 8.  Unravelling the mystery of capsaicin: a tool to understand and treat pain.

Authors:  Jessica O'Neill; Christina Brock; Anne Estrup Olesen; Trine Andresen; Matias Nilsson; Anthony H Dickenson
Journal:  Pharmacol Rev       Date:  2012-10       Impact factor: 25.468

9.  Altered pharmacology of native rodent spinal cord TRPV1 after phosphorylation.

Authors:  A J Mogg; C E J Mill; E A Folly; R E Beattie; M J Blanco; J P Beck; L M Broad
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

10.  Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy.

Authors:  Devang Kashyap Thakor; Audrey Lin; Yoshizo Matsuka; Edward M Meyer; Supanigar Ruangsri; Ichiro Nishimura; Igor Spigelman
Journal:  Mol Pain       Date:  2009-03-25       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.